Rafiq Nabi
Louisiana State University
H-index: 10
North America-United States
Top articles of Rafiq Nabi
The Oncolytic herpes simplex virus type-1 (HSV-1) vaccine strain VC2 causes intratumor infiltration of functionally active T cells and inhibition of tumor metastasis and pro …
Frontiers in Molecular Biosciences
2023/6/14
Rafiq Nabi
H-Index: 8
Oncolytic virotherapy with the HSV-1 (VC2) vaccine strain induces anti-tumor T-cell responses in the murine 4T1 breast cancer model
Cancer Research
2022/6/15
Rafiq Nabi
H-Index: 8
Konstantin Kousoulas
H-Index: 23
Intramuscular vaccination with the HSV-1 (VC2) live-attenuated vaccine strain confers protection against viral ocular immunopathogenesis associated with γδT cell intracorneal …
Frontiers in immunology
2021/11/15
Rafiq Nabi
H-Index: 8
Bispecific anti-HIV immunoadhesins that bind Gp120 and Gp41 have broad and potent HIV-neutralizing activity
Vaccines
2021/7/12
Rafiq Nabi
H-Index: 8
45724 VC2 Oncolytic Virotherapy Induces Robust Systemic Anti-Tumor Immunity and Increases Survival in an Immunocompetent B16F10-derived Mouse Melanoma Model
Journal of Clinical and Translational Science
2021/3
Novel oncolytic herpes simplex virus 1 VC2 promotes long-lasting, systemic anti-melanoma tumor immune responses and increased survival in an immunocompetent B16F10-derived …
Journal of virology
2021/1/13
Cover Image, Volume 92, Number 10, October 2020
Journal of Medical Virology
2020/10
Rafiq Nabi
H-Index: 8
The anti‐HIV drug nelfinavir mesylate (Viracept) is a potent inhibitor of cell fusion caused by the SARSCoV‐2 spike (S) glycoprotein warranting further evaluation as an …
Journal of medical virology
2020/10
Rafiq Nabi
H-Index: 8
Intramuscular vaccination of mice with the human herpes simplex virus type-1 (HSV-1) VC2 vaccine, but not its parental strain HSV-1 (F) confers full protection against lethal …
PLoS One
2020/2/6
Rafiq Nabi
H-Index: 8
